Hepatocellular carcinoma
Hepatocellular carcinoma (HCC), tí a tún pè ní malignant hepatoma, jẹ́ àrùn jẹjẹrẹ inú ẹ̀dọ tó wọ́pọ̀.
| Hepatocellular carcinoma | |
|---|---|
 | |
| Ìpínsọ́wọ̀ àti àwọn òkunfà ìta | |
| ICD/CIM-10 | C22.0 C22.0 |
| ICD/CIM-9 | 155 155 |
| MedlinePlus | 000280 |
Àwọn ìdí tí àrùn yìí lè fi wáyé ní nípasẹ̀ àkóràn kòkòrò jẹ̀dọ̀jẹ̀dọ̀ (Jẹ̀dọ̀jẹ̀dọ̀ B tàbí C), àwọn ohun tó lòdì sára bíi ògógóró tàbí aflatoxin, àwọn ìpò bíi hemochromatosis àti alpha 1-antitrypsin deficiency or NASH.[1]
Àwọn ìtọ́kasí àtúnṣe
- ↑ Kumar V, Fausto N, Abbas A (editors) (2015).
Ìwé àkàsíwájú si àtúnṣe
- "Long-term results of liver transplantation for hepatocellular carcinoma: an update of the University of Padova experience". September 23, 2013. Retrieved 6 February 2014.
- Bruix, Jordi; Sherman, Morris; Practice Guidelines Committee (November 2005). "Management of hepatocellular carcinoma". Hepatology 42 (5): 1208–1236. doi:10.1002/hep.20933. PMID 16250051.
- Liu, Chi-leung, M.D., "Hepatic Resection for Hepatocellular Carcinoma" Archived 2021-04-15 at the Wayback Machine., The Hong Kong Medical Diary, Vol.10 No.12, December 2005 Medical Bulletin